Exact Therapeutics Announces Clinical Trial Update
OSLO/LONDON, 08 March 2022: EXACT THERAPEUTICS AS (“EXACT-Tx”, Euronext Growth: EXTX), a clinical stage precision health company utilizing Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today provides an update regarding the phase I ACTIVATE study.